Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.74 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.61 |
| ▸ | CA4 | P22748 | 1/20 | 0.61 |
| ▸ | CA6 | P23280 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.57 |
| ▸ | STS | P08842 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15477907 | 0.94 | LIG1 (0.67) | LIG1SRD5A2KDM4ENAPRTHPGD | |
| SCHEMBL21802003 | 0.91 | LIG1 (0.87) | LIG1KDM4ENAPRTHPGDCA12 | |
| SCHEMBL29499085 | 0.91 | LIG1 (0.87) | LIG1KDM4ENAPRTHPGDCA12 | |
| Benzoic Acid SCHEMBL28785904 | 0.90 | LIG1 (0.72) | LIG1SRD5A2KDM4ENAPRTHPGD | |
| SCHEMBL28027482 | 0.89 | LIG1 (0.77) | LIG1SRD5A2KDM4ENAPRTHPGD | |
| SCHEMBL29390505 | 0.89 | LIG1 (0.76) | LIG1KDM4ENAPRTHPGDCA12 | |
| Benzene SCHEMBL6034371 | 0.89 | LIG1 (0.76) | LIG1KDM4ENAPRTHPGDCA12 | |
| SCHEMBL22129808 | 0.89 | LIG1 (0.76) | LIG1KDM4ENAPRTHPGDCA12 | |
| SCHEMBL36215 | 0.89 | LIG1 (0.76) | LIG1KDM4ENAPRTHPGDCA12 | |
| Phthalic Acid SCHEMBL11577907 | 0.88 | AKR1C3 (0.76) | LIG1KDM4ENAPRTHPGDCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0443742-B1 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 1997-10-01 | — | — | EP | claimed |
| US-5476754-A | Presensitized; hydrophilic surface on substrate; light sensitive layer containing alkaline water-soluble photocrosslinkable copolycondensed diazo resin | FUJI PHOTO FILM CO., LTD. (JP) | 1995-12-19 | — | — | US | claimed |
| EP-0443742-A2 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | claimed |
| US-12559458-B2 | Co-crystals or salts of psilocin and methods of treatment therewith | Reset Pharmaceuticals, Inc. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4486448-A1 | CO-CRYSTALS OR SALTS COMPRISING PSILOCIN | Reset Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| US-20240383849-A1 | CO-CRYSTAL OR SALT | Reset Pharmaceuticals, Inc. | 2024-11-21 | — | — | US | disclosed |
| CN-118871423-A | Co-crystals or salts comprising xylometacin | 雷塞特制药股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-12060328-B2 | Co-crystals or salts of psilocybin and methods of treatment therewith | Reset Pharmaceuticals, Inc. (US) | 2024-08-13 | — | — | US | disclosed |
| WO-2023168023-A1 | CO-CRYSTALS OR SALTS COMPRISING PSILOCIN | Reset Pharmaceuticals, Inc. (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023168022-A1 | CO-CRYSTALS OR SALTS COMPRISING PSILOCYBIN | Reset Pharmaceuticals, Inc. (US) | 2023-09-07 | — | — | WO | disclosed |
| US-20230279032-A1 | CO-CRYSTAL OR SALT | Reset Pharmaceuticals, Inc. | 2023-09-07 | — | — | US | disclosed |
| EP-0397375-B1 | Photosensitive composition and photosensitive lithographic printing plate | KONISHIROKU PHOTO IND (JP) | 1994-04-06 | — | — | EP | disclosed |
| US-5260161-A | Developability after storage for long time, press life, and ink attachibility | KONICA CORPORATION (JP) | 1993-11-09 | — | — | US | disclosed |
| US-5250393-A | Containing diazo resin and alkali metal or ammonium silicate | FUJI PHOTO FILM CO., LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0522457-A1 | Photosensitive composition | Mitsubishi Chemical Corporation (JP) | 1993-01-13 | — | — | EP | disclosed |
| EP-0492959-A1 | Method for developing presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1992-07-01 | — | — | EP | disclosed |
| EP-0487343-A1 | Process for preparing a lithographic plate | Fuji Photo Film Co., Ltd. (JP) | 1992-05-27 | — | — | EP | disclosed |
| EP-0443742-A2 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | disclosed |
| EP-0415422-A2 | Method for forming images | FUJI PHOTO FILM CO., LTD. (JP) | 1991-03-06 | — | — | EP | disclosed |
| EP-0397375-A1 | Photosensitive composition and photosensitive lithographic printing plate | KONICA CORPORATION (JP) | 1990-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383849-A1 | CO-CRYSTAL OR SALT | SLC6A3, SLC6A2, OPRK1 | LIG1 2544/4885SRD5A2 2947/4885KDM4E 2287/4885 |
| US-12060328-B2 | Co-crystals or salts of psilocybin and methods of treatment therewith | SLC6A3, SLC6A2, HTR2B | LIG1 3192/4885SRD5A2 3130/4885KDM4E 2484/4885 |
| US-20230279032-A1 | CO-CRYSTAL OR SALT | SLC6A3, SLC6A2, OPRK1 | LIG1 2544/4885SRD5A2 2947/4885KDM4E 2287/4885 |
| US-12559458-B2 | Co-crystals or salts of psilocin and methods of treatment therewith | SLC6A2, SLC6A4, SLC6A3 | LIG1 3197/4885SRD5A2 2164/4885KDM4E 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.